Evidence map›Paper›PMID 37945621›Full record

ArticleNPJ vaccines2023

Immunogenic arenavirus vector SIV vaccine reduces setpoint viral load in SIV-challenged rhesus monkeys.

Archana V Boopathy, Bhawna Sharma, Anurag Nekkalapudi, Raphaela Wimmer, Maria Gamez-Guerrero, Silpa Suthram, Hoa Truong, Johnny Lee, Jiani Li, Ross Martin and 8 more

Abstract read
In one paragraph

Article in NPJ vaccines, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

18 authors.

Archana V BoopathyGilead Sciences, Inc., Foster City, CA, 94404, USA. Archana.Boopathy@gilead.com.ORCID http://orcid.org/0009-0009-9164-0858
Bhawna SharmaGilead Sciences, Inc., Foster City, CA, 94404, USA.
Anurag NekkalapudiGilead Sciences, Inc., Foster City, CA, 94404, USA.
Raphaela WimmerHookipa Pharma Inc., New York, NY, 10018, USA.
Maria Gamez-GuerreroGilead Sciences, Inc., Foster City, CA, 94404, USA.
Silpa SuthramGilead Sciences, Inc., Foster City, CA, 94404, USA.
Hoa TruongGilead Sciences, Inc., Foster City, CA, 94404, USA.
Johnny LeeGilead Sciences, Inc., Foster City, CA, 94404, USA.
Jiani LiGilead Sciences, Inc., Foster City, CA, 94404, USA.
Ross MartinGilead Sciences, Inc., Foster City, CA, 94404, USA.
Wade BlairGilead Sciences, Inc., Foster City, CA, 94404, USA.
Romas GeleziunasGilead Sciences, Inc., Foster City, CA, 94404, USA.
Klaus OrlingerHookipa Pharma Inc., New York, NY, 10018, USA.
Sarah Ahmadi-ErberHookipa Pharma Inc., New York, NY, 10018, USA.
Henning LauterbachHookipa Pharma Inc., New York, NY, 10018, USA.ORCID http://orcid.org/0000-0002-6062-5163
Tariro MakadzangeGilead Sciences, Inc., Foster City, CA, 94404, USA.
Brie FalkardGilead Sciences, Inc., Foster City, CA, 94404, USA.
Sarah SchmidtHookipa Pharma Inc., New York, NY, 10018, USA. Sarah.Schmidt@hookipapharma.com.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

HIV affects more than 38 million people worldwide. Although HIV can be effectively treated by lifelong combination antiretroviral therapy, only a handful of patients have been cured. Therapeutic vaccines that induce robust de novo immune responses targeting HIV proteins and latent reservoirs will likely be integral for functional HIV cure. Our study shows that immunization of naïve rhesus macaques with arenavirus-derived vaccine vectors encoding simian immunodeficiency virus (SIV

Identifiers

PMID37945621
PMCPMC10635999

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.